These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20156065)

  • 41. Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved.
    Ostorhazi E; Holub MC; Rozgonyi F; Harmos F; Cassone M; Wade JD; Otvos L
    Int J Antimicrob Agents; 2011 May; 37(5):480-4. PubMed ID: 21353493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa.
    Santos DA; Nascimento MM; Vitali LH; Martinez R
    Rev Soc Bras Med Trop; 2013; 46(3):299-303. PubMed ID: 23856877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
    Cai Y; Chai D; Wang R; Liang B; Bai N
    J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.
    Drago L; De Vecchi E; Nicola L; Colombo A; Guerra A; Gismondo MR
    Chemotherapy; 2004 Oct; 50(4):202-10. PubMed ID: 15452399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
    Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N
    New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.
    Keen EF; Murray CK; Robinson BJ; Hospenthal DR; Co EM; Aldous WK
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):728-32. PubMed ID: 20500036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of the
    Avery LM; Abdelraouf K; Nicolau DP
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
    Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
    Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.
    Joly-Guillou ML; Wolff M; Farinotti R; Bryskier A; Carbon C
    J Antimicrob Chemother; 2000 Nov; 46(5):827-30. PubMed ID: 11062208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Chiang SR; Chuang YC; Tang HJ; Chen CC; Chen CH; Lee NY; Chou CH; Ko WC
    Crit Care Med; 2009 Sep; 37(9):2590-5. PubMed ID: 19623044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii.
    Bowers DR; Cao H; Zhou J; Ledesma KR; Sun D; Lomovskaya O; Tam VH
    Antimicrob Agents Chemother; 2015 May; 59(5):2720-5. PubMed ID: 25712362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bactericidal kinetics of an in vitro infection model of once-daily ceftriaxone plus amikacin against gram-positive and gram-negative bacteria.
    Scaglione F; Dugnani S; Demartini G; Arcidiacono MM; Cocuzza CE; Fraschini F
    Chemotherapy; 1995; 41(4):239-46. PubMed ID: 7555203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of antivirulence activity of several d-amino acids against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Rumbo C; Vallejo JA; Cabral MP; Martínez-Guitián M; Pérez A; Beceiro A; Bou G
    J Antimicrob Chemother; 2016 Dec; 71(12):3473-3481. PubMed ID: 27605598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.